file1
,
file2
, etc. all in the same folder or directory;
first, locate one of the files with the [Browse...] button. Then alter the
file path in the box above to include '*' character (eg. file*
).
Wildcard '?' to blanket only one character works too.Historiographs |
Grand Totals: LCS 17722, GCS 106366, CR 136943 Collection span: 1963 - 2012 | |
Word(i) List (4568) Word count: 24159, All words count: 34321 |
# | Word | Recs | TLCS | TGCS |
---|---|---|---|---|
2401 | ACCUMULATE | 1 | 1 | 37 |
2402 | ACHIEVE | 3 | 1 | 9 |
2403 | ACHIEVED | 3 | 1 | 25 |
2404 | ACTIONS | 2 | 1 | 19 |
2405 | ADVANCING | 1 | 1 | 19 |
2406 | ADVERSELY | 1 | 1 | 7 |
2407 | AFFECTED | 1 | 1 | 7 |
2408 | AGGRAVATE | 1 | 1 | 4 |
2409 | ALIMENTARY-TRACT | 1 | 1 | 45 |
2410 | ALLELE-SPECIFIC | 1 | 1 | 4 |
2411 | ALLOANTIBODY-MEDIATED | 1 | 1 | 22 |
2412 | ALLOANTIGEN-PRESENTING | 1 | 1 | 8 |
2413 | ALLOIMMUNITY | 1 | 1 | 34 |
2414 | ALLOSPECIFIC | 1 | 1 | 23 |
2415 | ALLOTRANSPLANTS | 2 | 1 | 5 |
2416 | ALTERING | 1 | 1 | 11 |
2417 | ANATOMICAL | 1 | 1 | 18 |
2418 | ANESTHESIA | 3 | 1 | 4 |
2419 | ANESTHETIC | 2 | 1 | 33 |
2420 | ANGIOGRAMS | 1 | 1 | 10 |
2421 | ANGIOGRAPHIC | 2 | 1 | 4 |
2422 | ANIMAL-MODELS | 1 | 1 | 16 |
2423 | ANTI-ALPHA | 2 | 1 | 1 |
2424 | ANTI-HOST | 1 | 1 | 32 |
2425 | ANTI-INTERLEUKIN-2 | 1 | 1 | 26 |
2426 | ANTI-THY | 1 | 1 | 14 |
2427 | ANTICLASS-I | 1 | 1 | 6 |
2428 | ANTIGEN-INDUCED | 3 | 1 | 29 |
2429 | ANTIGENEMIA | 1 | 1 | 34 |
2430 | ANTIGENIC | 2 | 1 | 2 |
# | Word | Recs | TLCS | TGCS |
2431 | ANTIGLOBULIN-TEST | 1 | 1 | 1 |
2432 | ANTILYMPHOBLAST-GLOBULIN | 1 | 1 | 13 |
2433 | ANTIRAT | 1 | 1 | 11 |
2434 | AORTORENAL | 1 | 1 | 10 |
2435 | APIGENIN | 1 | 1 | 14 |
2436 | APLASIA | 3 | 1 | 21 |
2437 | ARRAY | 1 | 1 | 17 |
2438 | ART | 2 | 1 | 12 |
2439 | ARTERIAL-DISEASE | 1 | 1 | 163 |
2440 | ARTERIOSCLEROSIS | 1 | 1 | 163 |
2441 | ARTICLE | 1 | 1 | 4 |
2442 | ASSESSING | 1 | 1 | 53 |
2443 | ASYMMETRIC-SYNTHESIS | 1 | 1 | 4 |
2444 | ATTEMPT | 1 | 1 | 3 |
2445 | ATTEMPTS | 2 | 1 | 15 |
2446 | ATTENUATES | 1 | 1 | 26 |
2447 | AUTOANTIBODY | 1 | 1 | 9 |
2448 | AUTOCREATE | 1 | 1 | 4 |
2449 | AUTOIMMUNE-PRONE | 1 | 1 | 16 |
2450 | AZATHIOPRINE-ANTILYMPHOCYTEIMMUNO-GLOBULIN-G | 1 | 1 | 8 |
2451 | B-LYMPHOCYTES | 2 | 1 | 16 |
2452 | BACTERIAL | 2 | 1 | 75 |
2453 | BARRIERS | 3 | 1 | 37 |
2454 | BASOPHILIC | 1 | 1 | 5 |
2455 | BEHCET | 1 | 1 | 18 |
2456 | BENCH | 1 | 1 | 26 |
2457 | BENEATH | 1 | 1 | 19 |
2458 | BETA-TCR | 1 | 1 | 1 |
2459 | BIDIRECTIONAL | 2 | 1 | 4 |
2460 | BILIARY-EXCRETION | 1 | 1 | 70 |
# | Word | Recs | TLCS | TGCS |
2461 | BIOSYNTHESIS | 1 | 1 | 25 |
2462 | BIVALENT | 1 | 1 | 2 |
2463 | BLACK | 1 | 1 | 4 |
2464 | BLOCKING | 2 | 1 | 18 |
2465 | BONE-MARROW-AUGMENTED | 1 | 1 | 1 |
2466 | BOOSTING | 1 | 1 | 5 |
2467 | BP-12 | 1 | 1 | 15 |
2468 | BRAIN | 3 | 1 | 84 |
2469 | BRAIN-STEM | 1 | 1 | 30 |
2470 | BRAVE | 1 | 1 | 106 |
2471 | BREQUINAR | 1 | 1 | 18 |
2472 | BRONCHOALVEOLAR | 1 | 1 | 5 |
2473 | BURNS | 1 | 1 | 7 |
2474 | C-14-LABELED | 1 | 1 | 3 |
2475 | C-28-C-34 | 1 | 1 | 4 |
2476 | CAPABLE | 1 | 1 | 5 |
2477 | CAPSULE | 1 | 1 | 19 |
2478 | CARTILAGE | 1 | 1 | 2 |
2479 | CD40IG | 1 | 1 | 25 |
2480 | CEREBELLAR | 1 | 1 | 30 |
2481 | CHARACTERISTIC | 1 | 1 | 3 |
2482 | CHARACTERIZED | 1 | 1 | 16 |
2483 | CHEMISTS | 1 | 1 | 20 |
2484 | CHOLESTASIS | 1 | 1 | 18 |
2485 | CHROMOSOME | 4 | 1 | 33 |
2486 | CIRCULATION | 2 | 1 | 94 |
2487 | CLEVELAND | 2 | 1 | 4 |
2488 | CLINICAL-PHARMACOLOGY | 1 | 1 | 66 |
2489 | CLINICAL-TRIALS | 1 | 1 | 7 |
2490 | CLINICO-PATHOLOGICAL | 1 | 1 | 3 |
# | Word | Recs | TLCS | TGCS |
2491 | CLIP | 1 | 1 | 3 |
2492 | CLOSE | 1 | 1 | 18 |
2493 | COMA | 1 | 1 | 71 |
2494 | COMPARABLE | 1 | 1 | 37 |
2495 | COMPARATIVE-STUDIES | 1 | 1 | 15 |
2496 | COMPARTMENTAL | 1 | 1 | 8 |
2497 | COMPLEX-MISMATCHED | 1 | 1 | 13 |
2498 | COMPLICATING | 1 | 1 | 21 |
2499 | COMPRESSION | 1 | 1 | 30 |
2500 | COMPUTER | 1 | 1 | 8 |
2501 | CONDYLAR | 1 | 1 | 2 |
2502 | CONFLICTING | 1 | 1 | 19 |
2503 | CONNECTION | 1 | 1 | 5 |
2504 | CONSTANT | 1 | 1 | 28 |
2505 | CONSTRUCT | 1 | 1 | 21 |
2506 | CONTEMPORARY | 1 | 1 | 4 |
2507 | CONVENTIONAL | 1 | 1 | 33 |
2508 | COST-EFFECTIVE | 1 | 1 | 8 |
2509 | CRAFTS | 1 | 1 | 2 |
2510 | CREATION | 1 | 1 | 6 |
2511 | CROSS | 1 | 1 | 71 |
2512 | CROSS-MATCH | 1 | 1 | 4 |
2513 | CROSS-MATCH-NEGATIVE | 1 | 1 | 9 |
2514 | CROSSMATCH | 1 | 1 | 53 |
2515 | CROSSROADS | 1 | 1 | 104 |
2516 | CSA | 1 | 1 | 10 |
2517 | CTA | 1 | 1 | 11 |
2518 | CTLA4IGM | 1 | 1 | 13 |
2519 | CYCLOHEXYL | 1 | 1 | 4 |
2520 | CYTO-TOXIC | 2 | 1 | 58 |
# | Word | Recs | TLCS | TGCS |
2521 | CYTOMEGALOVIRUS-FREE | 1 | 1 | 34 |
2522 | CYTOSTATICUM | 1 | 1 | 5 |
2523 | DACLIZUMAB | 2 | 1 | 43 |
2524 | DAMAGED | 1 | 1 | 17 |
2525 | DECADES | 1 | 1 | 13 |
2526 | DECISION | 2 | 1 | 17 |
2527 | DELAYED-HYPERSENSITIVITY | 1 | 1 | 62 |
2528 | DELIVERIES | 1 | 1 | 2 |
2529 | DEMONSTRATION | 1 | 1 | 12 |
2530 | DERIVATIVE | 1 | 1 | 23 |
2531 | DERMATOSES | 1 | 1 | 16 |
2532 | DETERMINES | 2 | 1 | 5 |
2533 | DEVELOPMENTAL | 1 | 1 | 34 |
2534 | DEVELOPMENTS | 5 | 1 | 95 |
2535 | DIABETIC | 6 | 1 | 38 |
2536 | DIMINISHED | 1 | 1 | 8 |
2537 | DISCREPANCIES | 1 | 1 | 31 |
2538 | DISORDER | 3 | 1 | 54 |
2539 | DMBA | 1 | 1 | 53 |
2540 | DOCUMENTATION | 1 | 1 | 1 |
2541 | DONOR-AND-RECIPIENT-DERIVED | 1 | 1 | 3 |
2542 | DONOR-HOST | 1 | 1 | 8 |
2543 | DONOR-MAJOR | 1 | 1 | 5 |
2544 | DOSE-RESPONSE | 2 | 1 | 10 |
2545 | DROPS | 1 | 1 | 7 |
2546 | DSG | 1 | 1 | 16 |
2547 | DUALISTIC | 1 | 1 | 9 |
2548 | DYNAMICS | 2 | 1 | 9 |
2549 | DYSPLASIA | 1 | 1 | 111 |
2550 | EDEMA | 1 | 1 | 30 |
# | Word | Recs | TLCS | TGCS |
2551 | EDENTULOUS | 1 | 1 | 18 |
2552 | EFFECTIVE | 4 | 1 | 35 |
2553 | EFFECTOR | 1 | 1 | 8 |
2554 | EFFLUX | 2 | 1 | 81 |
2555 | ELECTRONMICROSCOPIC | 1 | 1 | 6 |
2556 | EMERGENCIES | 2 | 1 | 4 |
2557 | ENCOUNTERED | 1 | 1 | 10 |
2558 | ENERGY | 2 | 1 | 16 |
2559 | ENGAGEMENT | 1 | 1 | 9 |
2560 | ENIGMA | 1 | 1 | 5 |
2561 | ENTIRE | 1 | 1 | 2 |
2562 | ENVIRONMENT | 1 | 1 | 10 |
2563 | ENZYMOLOGY | 1 | 1 | 25 |
2564 | EPIDERMAL | 2 | 1 | 86 |
2565 | EPIDERMAL-CELL | 1 | 1 | 46 |
2566 | EPITHELIAL-CELLS | 1 | 1 | 4 |
2567 | ERYTHROPOIESIS | 2 | 1 | 25 |
2568 | EVOKED | 1 | 1 | 34 |
2569 | EXISTENCE | 1 | 1 | 1 |
2570 | EXPANDING | 1 | 1 | 11 |
2571 | EXPECTATIONS | 2 | 1 | 16 |
2572 | EXPERIMENT | 1 | 1 | 4 |
2573 | EXTENDS | 1 | 1 | 13 |
2574 | EXTENT | 1 | 1 | 2 |
2575 | EXTRAMEDULLARY | 1 | 1 | 21 |
2576 | EXTREME | 1 | 1 | 28 |
2577 | EYE | 2 | 1 | 7 |
2578 | FACTOR-BASED | 1 | 1 | 5 |
2579 | FIBERS | 1 | 1 | 18 |
2580 | FIBRINOGEN | 1 | 1 | 24 |
# | Word | Recs | TLCS | TGCS |
2581 | FIBROMUSCULAR | 1 | 1 | 111 |
2582 | FILTERS | 2 | 1 | 21 |
2583 | FK-BINDING | 1 | 1 | 8 |
2584 | FK779 | 1 | 1 | 22 |
2585 | FLUSHED | 1 | 1 | 3 |
2586 | FOLDING | 2 | 1 | 135 |
2587 | FORMULATION | 2 | 1 | 69 |
2588 | FOXP3 | 2 | 1 | 58 |
2589 | FRAGMENT | 1 | 1 | 4 |
2590 | FRET | 1 | 1 | 4 |
2591 | FRONTIERS | 2 | 1 | 17 |
2592 | FUNCTIONAL-CHARACTERIZATION | 1 | 1 | 9 |
2593 | FUTURE-THE | 1 | 1 | 11 |
2594 | GALECTIN-1 | 2 | 1 | 24 |
2595 | GANCICLOVIR | 1 | 1 | 34 |
2596 | GENDER | 4 | 1 | 134 |
2597 | GENE-EXPRESSION | 2 | 1 | 9 |
2598 | GENETIC | 6 | 1 | 68 |
2599 | GOODPASTURES | 1 | 1 | 30 |
2600 | GOVERNED | 1 | 1 | 4 |